AOI Medical

AOI Medical was a medical technology company focused on developing and commercializing innovative orthopedic and spinal surgical devices. The company's primary focus was the treatment of vertebral compression fractures (VCF) through its proprietary In-Spire and Ascent LE systems. These devices were designed as minimally invasive alternatives to traditional kyphoplasty and vertebroplasty, aiming to provide superior height restoration and structural stabilization. Headquartered in Orlando, Florida, the company was publicly traded on the London Stock Exchange's AIM market. Following significant financial challenges and a failure to secure additional funding, AOI Medical sold its core intellectual property to Kensey Nash in 2011 and subsequently underwent liquidation.